Allison Gaw is a Principal at Amplitude, having joined after helping to grow, mature, and set up multiple biotech startups for exit. An experienced life science and drug development business professional with 20 years of experience managing strategy at the interface of science and business, Allison supports Amplitude’s funds in driving investments in precision medicine technologies from Canada and the US and advising strategic planning and business development for portfolio companies.
Allison’s previous roles include VP of Business Development at Chinook Therapeutics (acquired by Novartis) and Senior Director of Business Development, IP, and Corporate Strategy at Sierra Oncology (acquired by GSK). Allison was also a consultant at Boston Consulting Group and LEK Consulting. She holds a BS and an MS in biological sciences from Stanford University, and an MBA in health care management from the University of Pennsylvania’s Wharton School of Business.